Thu, Apr 27, 2017 | updated 05:00 AM IST

New drug can extends the life span of Melanoma patients

Updated: Oct 01, 2016 14:55 IST      
New drug can extends the life span of Melanoma patients

London [England], Oct. 1 (ANI): An advance drug that utilizes a human-made virus to treat later stage skin cancer, Melanoma has been approved for use.

The novel medicine, which doubles average survival time for people with inoperable melanoma, is to be provided to patients for whom other drugs do not work, after NHS (National Health Service) recommended it for immediate use, reports Daily Mail.

The therapy, known as T-VEC, works by infecting and killing cancer cells with a genetically-modified form of the herpes virus.

The drug also harnesses the power of the body's own immune system and directs it against tumours.

Remarkably, it does this without harming healthy human cells, as a result having fewer side effects than chemotherapy and other cancer treatments.

Trials led by the Institute of Cancer Research in London showed that terminally-ill patients treated with the fortnightly injections lived for an average of 41 months.

Patients treated with another modern drug, an immunotherapy which until now was considered one of the best treatments for metastatic skin cancer, only lived for 21 months.

Rates of the disease have shot up by 360 per cent since the 1970s in UK, which experts blame on the rise of cheap package holiday deals and sunbathing.

Lead researcher Kevin Harrington said, "It is very exciting news that NICE has approved T-VEC for patients with advanced melanoma, making it the first of its kind to be

approved for use on the NHS. This is the culmination of ten years' work on this agent."

"T-VEC is a modified form of the herpes virus and kills cancer cells in two ways - by attacking them directly and by directing the patient's own immune system against the tumour. The treatment has not only been shown to be effective, but has relatively mild side-effects making it particularly suitable for patients who can't be given some of the other immunotherapies on the market," he added.

Scientists developed T-VEC by modifying the herpes simplex virus, which causes cold sores, to attack cancer cells but be harmless to healthy cells.

It multiplies within cancer cells and bursts them from within, but scientists removed two key genes so that the virus cannot replicate in non-cancerous cells.

T-VEC also releases a molecule which stimulates the immune system to attack the cancer, resulting in a twin attack from inside and outside the cancer cells.

Initially it has been approved for use for patients with inoperable malignant melanoma, for whom immunotherapy drugs would not work.

Roughly 100 patients a year are expected to benefit at first, but this number may rise in the future if it is judged to be suitable for use at an earlier stage.

John Kearney, from the drugs company, which sells the drug under the brand name Imlygic, said, "Melanoma still takes too many lives each year. New medicines based on cutting-edge science, such as Imlygic, are playing their part in improving the ways that doctors and the health service as a whole can help people affected in the future."

"The scientists who invented and developed the technology leading to Imlygic really deserve to be remembered and celebrated today - as a company, they make us very proud," he added. (ANI)

Lung for Long: Gasp No More

Updated: Apr 26, 2017 18:45 IST     

New Delhi [India], Apr 26 (ANI-Businesswire India): Lungs in Delhi seem to be in dire straits. In the midst of ever thickening air pollution and lifestyle gone astray, lung power is ebbing fast. Data emerging from April 25 lung health camp organized in iconic Press Club of India (PCI) on the occasion of World Asthma Day pressed panic button as regards lung health of the capital city.

Full Story >>

Risk of obesity influenced by changes in our genes

Updated: Apr 26, 2017 15:22 IST     

New Delhi [India], Apr 26 (ANI): According to new study, a child's risk of obesity while growing up can be influenced by modifications to their DNA prior to birth.

Full Story >>

Patient with rare knee cancer undergoes life saving surgery

Updated: Apr 26, 2017 13:52 IST     

New Delhi [India], Apr 26 (ANI): A resident of Ganganager, in Rajasthan, was diagnosed of Large Soft Tissue Sarcoma (9Kg), with Neuro Vascular involvement.

Full Story >>

Here`s how protein impacts intellectual disability

Updated: Apr 26, 2017 07:36 IST     

Washington D.C. [USA], Apr 26 (ANI): A new study has paved the way for the potential treatments of intellectual disability and other neurodevelopmental disorders.

Full Story >>

Stem cells can help identify neuronal defects, suggests Study

Updated: Apr 25, 2017 12:26 IST     

Washington D.C. [USA], Apr 25 (ANI): According to a recent study, the researchers used stem cells derived from patients with Angelman syndrome to identify the underlying cellular defects that cause the rare neurogenetic disorder.

Full Story >>

#WorldMalariaDay: Effective steps to prevent Malaria

Updated: Apr 25, 2017 11:01 IST     

New Delhi [India], Apr 25 (ANI): The theme for World Malaria Day this year is "End Malaria for Good".

Full Story >>

Artificial Intelligence may help in diagnosing Tuberoculosis

Updated: Apr 25, 2017 11:01 IST     

Washington D.C. [USA], Apr 25 (ANI): If you are a patient of Tuberculosis, then we might have some good news for you.

Full Story >>

London [UK], Apr 25 (ANI): According to a new study, only one in five victims with serious injuries caused by child abuse in England and Wales gets treated at a major trauma centre.

Full Story >>

Gene reveals cause of fatal childhood disorder: Study

Updated: Apr 24, 2017 17:51 IST     

New Delhi [India], Apr 24 (ANI): A gene, involved in brain development, which can lead to severe disability and infant death, has been identified by scientists.

Full Story >>

Alcohol: the modern age liver killer

Updated: Apr 24, 2017 17:51 IST     

New Delhi [India], Apr 24 (ANI): Alcohol is predominantly metabolized through liver, hence its cumulative toxicity over years play important role in liver diseases or pancreatic diseases.

Full Story >>

Washington D.C. [USA], April 24 (ANI): Due to increasing deaths because of prostate cancer among men, US researchers have suggested a special screening more frequently and at an early age to avoid the development of preclinical prostate cancer - that is not symptomatic - to advanced stages.

Full Story >>

Love guzzling diet sodas? Here is why you should NOT

Updated: Apr 24, 2017 07:02 IST     

New York [U.S.], Apr. 24 (ANI): Still downing gallons of diet soda despite knowing that it wrecks your body? Maybe the knowledge of artificially sweetened beverages taking a toll on your brain as well ought to make an impact on your unhealthy habit.

Full Story >>

Washington D.C. [USA], Apr 23 (ANI): A recent study has demonstrated that in the general population, central obesity, insulin resistance, diabetes, lipid abnormalities and high alcohol consumption were the strongest predictors of severe liver disease.

Full Story >>

Breastmilk may help detect your cancer risk

Updated: Apr 23, 2017 11:50 IST     

Washington D.C. [USA], Apr 23 (ANI): Breastmilk might offer clues about a woman's cancer risk, according to a recent research.

Full Story >>

Soon, new weapon in war against obesity

Updated: Apr 23, 2017 11:14 IST     

Washington D.C. [USA], Apr 23 (ANI): A team of scientists has uncovered a potential approach to combat obesity.

Full Story >>

Turns out, being obese is worse than smoking

Updated: Apr 23, 2017 10:52 IST     

Washington D.C. [USA], Apr 23 (ANI): You may want to shed those extra kilos as a recent study has found obesity as a top cause of preventable life-years lost.

Full Story >>

Washington D.C. [USA], Apr 23 (ANI): Testing for molecular markers in the urine of kidney transplant patients could reveal whether the transplant is failing and why, according to a recent research.

Full Story >>

From urine to blood: How antibiotic resistance spreads

Updated: Apr 23, 2017 09:25 IST     

Washington D.C. [USA], Apr 23 (ANI): People with drug-resistant bacteria in their urine or stool samples are at an increased risk of developing Sepsis, a bloodstream infection that is also resistant to certain antibiotics, according to a recent study.

Full Story >>

Move over contact lenses, LASIK is better

Updated: Apr 22, 2017 18:05 IST     

Washington D.C. [USA], April 22 (ANI): Good news for those who underwent LASIK (laser-assisted in situ keratomileusis) for correction of their vision, as a recent study has found that the rate of cornea infection is lower.

Full Story >>

Early detection of oral cancer can increase survival chances

Updated: Apr 22, 2017 08:03 IST     

New Delhi [India], Apr. 22 (ANI): In today's era of booming medical advancements, the chances of survival from cancer can be increased, if it is detected at an early stage.

Full Story >>